Prospective, controlled, randomized study enrolled 100 patients with acute anterior STEMI eligible for primary PCI equally divided into 2 groups (group A received bolus intracoronary eptifibatide and group B received it intravenous) followed by 12h continuous IV infusion. Predictors of myocardial salvage in the form of TIMI flow grade III, myocardial blush grade 3, ST segment resolution and lef...

the composition of essential oil of leaves of the male and female shrubs of juniperus chinensis l. (growing in isfahan) was analyzed by gas choromatography(gc) and gc-mass spectrometery (ms). the main constituents of leaf oil of the male shrub were: bornyl acetate (26.1%), sabinene (18.3%), trans-sabinyl acetate (11.1%), myrcene (9.2%), limonene (6.1%), elemol (5.5%), α-cadinol (2.3%), δ-cadine...

The role of GP IIb/IIIa antagonists has been focused on patients with acute coronary syndromes undergoing PCI. In the ISAR-REACT 2 study abciximab given in patients with NSTEACS undergoing PCI already treated with 600 mg clopidogrel improved 30-day death and reinfarction rate in troponin positive patients. In the large EARLY-ACS trial upstream therapy with eptifibatide in high risk with NSTE-AC...

antiplatelet treatment Offer a single loading dose of 300 mg aspirin as soon as possible and continue indefinitely unless contraindicated by bleeding risk or aspirin hypersensitivity. [Based on a high quality systematic review and cost effectiveness evidence] Offer a loading dose of 300 mg clopidogrel in addition to aspirin to patients with a predicted six month mortality of more than 1.5%, or ...

Clinical Case A 58-year-old male was presented with an ST-elevation inferior myocardial infarction. Emergency medical services administered 325 mg of aspirin and sublingual nitroglycerin en route to the emergency room. In the emergency room, the patient received 600 mg of clopidogrel and a heparin bolus. Coronary angiography revealed complete occlusion of the distal right coronary artery with t...